ArticleJournal of experimental & clinical cancer research : CR2022

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer.

Mila Gugnoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.